183 related articles for article (PubMed ID: 9743157)
41. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.
Høgåsen AK; Overlie I; Hansen TW; Abrahamsen TG; Finne PH; Høgåsen K
J Perinat Med; 2000; 28(1):39-48. PubMed ID: 10765513
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic significance of interferon-gamma in tuberculous pleural effusions.
Aoe K; Hiraki A; Murakami T; Eda R; Maeda T; Sugi K; Takeyama H
Chest; 2003 Mar; 123(3):740-4. PubMed ID: 12628872
[TBL] [Abstract][Full Text] [Related]
43. Serum complement components in Henoch-Schönlein purpura.
Garcia-Fuentes M; Martin A; Chantler C; Williams DG
Arch Dis Child; 1978 May; 53(5):417-9. PubMed ID: 666358
[TBL] [Abstract][Full Text] [Related]
44. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
[TBL] [Abstract][Full Text] [Related]
45. Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions.
Lew PD; Zubler R; Vaudaux P; Farquet JJ; Waldvogel FA; Lambert PH
J Clin Invest; 1979 Feb; 63(2):326-34. PubMed ID: 429556
[TBL] [Abstract][Full Text] [Related]
46. T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions.
Okamoto M; Hasegawa Y; Hara T; Hashimoto N; Imaizumi K; Shimokata K; Kawabe T
Chest; 2005 Dec; 128(6):4030-5. PubMed ID: 16354877
[TBL] [Abstract][Full Text] [Related]
47. Complement activity in middle ear effusions.
Bernstein JM; Schenkein HA; Genco RJ; Bartholomew WR
Clin Exp Immunol; 1978 Aug; 33(2):340-6. PubMed ID: 102478
[TBL] [Abstract][Full Text] [Related]
48. [Adenosine deaminase activity in tuberculous and malignant pleural effusions].
Safianowska A; Krenke R; Dmowska-Sobstyl B; Bogacka-Zatorska E; Domagała-Kulawik J; Chazan R
Pneumonol Alergol Pol; 2006; 74(1):5-9. PubMed ID: 17175968
[TBL] [Abstract][Full Text] [Related]
49. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
Gyongyossy-Issa MI; McLeod E; Devine DV
J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
[TBL] [Abstract][Full Text] [Related]
50. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
[No Abstract] [Full Text] [Related]
51. [Complement in rheumatoid articular inflammation].
Boloşiu HD; Duţu A; Duţu D; Duma V; Gligore V
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975; 27(6):469-74. PubMed ID: 3842
[No Abstract] [Full Text] [Related]
52. Diagnosis of tuberculosis in patients with pleural effusion in an area of HIV infection and limited diagnostic facilities.
Richter C; Perenboom R; Swai AB; Kitinya J; Mtoni I; Chande H; Kazema RR; Chuwa LM; Mwakyusa DH; Maselle SY
Trop Geogr Med; 1994; 46(5):293-7. PubMed ID: 7855915
[TBL] [Abstract][Full Text] [Related]
53. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
Petersen NE; Elmgreen J; Teisner B; Svehag SE
Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
[TBL] [Abstract][Full Text] [Related]
54. Simultaneous measurement of T-helper 1 cytokines in tuberculous pleural effusion.
Hiraki A; Aoe K; Matsuo K; Murakami K; Murakami T; Onoda T; Sugi K; Takeyama H; Eda R
Int J Tuberc Lung Dis; 2003 Dec; 7(12):1172-7. PubMed ID: 14677892
[TBL] [Abstract][Full Text] [Related]
55. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
[TBL] [Abstract][Full Text] [Related]
56. Systemic complement fixation after fractures.
Bamberger J; Freed DL; Banks AJ; Maltby B
Lancet; 1978 Feb; 1(8060):395-6. PubMed ID: 75433
[No Abstract] [Full Text] [Related]
57. The role of immune complexes in the pathogenesis of pleural effusions.
Andrews BS; Arora NS; Shadforth MF; Goldberg SK; Davis JS
Am Rev Respir Dis; 1981 Aug; 124(2):115-20. PubMed ID: 7258825
[TBL] [Abstract][Full Text] [Related]
58. [Consumption hypocomplementemia: comparative value of haemolytic and protein estimations of the components of the classical pathway (author's transl)].
Roncato M; Vial MC; Maillet F; Peltier A
Nouv Presse Med; 1979 May; 8(20):1657-60. PubMed ID: 112575
[TBL] [Abstract][Full Text] [Related]
59. Antiphospholipid antibodies and complement activation in patients with cerebral ischemia.
Davis WD; Brey RL
Clin Exp Rheumatol; 1992; 10(5):455-60. PubMed ID: 1458697
[TBL] [Abstract][Full Text] [Related]
60. Assaying of tumor necrosis factor alpha, complement factors, and alpha-1-antitrypsin in the diagnosis of malignant serous effusions.
Alexandrakis MG; Kyriakou D; Koutroubakis IE; Alexandraki R; Vlachonikolis IG; Eliopoulos GD
Am J Clin Oncol; 2001 Dec; 24(6):562-5. PubMed ID: 11801754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
